摘要:
An atomic magnetometer system is disclosed that includes a variable magnetic field source (14) configured to provide an oscillating primary magnetic field to cause a sample (16) to produce a secondary magnetic field. The atomic magnetometer system also includes an atomic magnetometer for detecting the secondary magnetic field. The atomic magnetometer includes an atomic specimen, a pump and probe subsystem configured to pump the atomic specimen to create a polarisation and to probe atomic coherence precession within the atomic specimen with a probe beam, a detector configured to detect the probe beam to produce a detection signal. The system is configured to drive the variable magnetic field source (14) in dependence on the detection signal with a frequency tuned to rf resonance. A method of operating an atomic magnetometer is also disclosed.
摘要:
Apparatus for powering devices, comprising a power supply having inputs from two or more different power sources; means for combining the power sources and providing a power supply to one or more end devices; means for comparing the two input power sources and generating an index representative of the relative proportions of each at any time and means for using the index to determine how the power is utilised.
摘要:
In the simulation of a spatially-extended physical process the complete spatial extent of which is defined by a multiplicity of parameters, each parameter is represented with a multi-state distinguished sequential digital logic circuit the possible states of which represent the possible states of the pertaining parameter. The interaction of each pair of parameters is represented with an interconnection between the pertaining circuits. Each logic circuit is initially established in a known state and thereafter at least one circuit is pulsed to cause evolution of the circuits through some or all of their possible states. The states of certain circuits are determined intermittently as a measure of the corresponding states of the parameters.
摘要:
An apparatus is disclosed for monitoring physiological parameters comprising a harness adapted to be worn by a human being and electrical circuitry connected to the harness for calculating physiological parameters in accordance with predetermined algorithms. The harness includes a band which extends around a trunk portion of the human being. The band comprises an inelastic portion and an elastic portion. The elastic portion incorporates an electro-conductive elastomeric means which has a resistance value which changes as a function of elongation of the elastic portion. The electrical circuitry connected to the elastomeric element calculates and displays various physiological parameters.
摘要:
Disclosed herein are methods and devices for the inactivation of pathogens (e.g., bacteria, viruses, etc.) in ex vivo stored blood products, such as plasma and/or platelets, by means of directing visible light radiation from an illuminating device into blood product storage containers in order to achieve effective pathogen inactivation without the presence of an added photosensitising agent in the blood product. An exemplary apparatus includes a control unit that operates a light source that emits light in the wavelength region of about 380-500 nm which is directed onto blood product storage bags at sufficient intensity to penetrate the bag material and the opaque blood product therein in order to inactivate pathogens in the blood product but at dose levels that cause no significant detrimental effects on the blood product.
摘要:
Disclosed herein are novel compounds for treating apicomplexan parasite related disorders, methods for their use; cell line and non-human animal models of the dormant parasite phenotype and methods for their use in identifying new drugs to treat apicomplexan parasite related disorders, and biomarkers to identify disease due to the parasite and its response to treatment.
摘要:
Disclosed herein is a method of detecting a material response. The method includes providing an oscillating primary magnetic field to cause as ample to produce a secondary magnetic field. The method also includes reducing the effect on an atomic magnetometer of components of the primary and secondary magnetic fields in a direction substantially orthogonal to a surface of the sample. The method also includes detecting the secondary magnetic field with the atomic magnetometer to detect the material response.
摘要:
Disclosed herein; are novel compounds for treating apicomplexan parasite related disorders, methods for their use; cell line and non-human animal models of the dormant parasite phenotype and methods for their use in identifying new drugs to treat apicomplexan parasite related disorders, and biomarkers to identify disease due to the parasite and its response to treatment.
摘要:
The present invention relates to a peptide derivative represented by the general formula (I) or a salt thereof: Z-(CH2)n—CO—NH-Leu-Ile-Gly-AA1-AA2-CO—R (I) wherein Z represents an aryl group which may or may not have a substituent or a heteroaryl group which may or may not have a substituent; n represents 0, 1 or 2: AA1-AA2 represents Lys-Val or Arg-Leu; and R represents —OH or —NH2, and relates to a pharmaceutical composition comprising a peptide derivative represented by the general formula (I) or a salt thereof, and a pharmaceutically acceptable carrier thereof. The peptide derivative is useful as a prophylactic and therapeutic agent of dysfunction of masticatory, dysphagia, dysgeusia, ozostomia, intra-oral cavity dysphoria, intra-oral cavity infections, intra-oral cavity inflammations, dry eye, ectocornea detachment, keratitis, corneal ulcer, conjunctivitis, stomach ulcer, duodenal ulcer, gastritis, diarrhea, enteritis or Sjogren's syndrome.
摘要:
The present invention relates to the preparation of substantially pure diastereoisomers of derivatives of tetrahydrofolate and the use of such diastereoisomers. More particularly the present invention provides a process for the preparation of a desired substantially pure (6R or 6S) diastereoisomer of a derivative of tetrahydrofolic acid or salt or ester. The process comprises the steps of: attaching a chiral auxiliary group at either N-5 or N-10 of a mixture of 6R and 6S diastereoisomers of tetrahydrofolic acid, separating the new diastereoisomers, recovering the desired new diastereoisomer (6R or 6S) corresponding to the desired (6R or 6S) diastereoisomer, and converting the substantially pure new diastereoisomer recovered into the corresponding diastereoisomer.